Chronic mild stress alters synaptic plasticity in the nucleus accumbens through GSK3β-dependent modulation of Kv4.2 channels
Chronic mild stress alters synaptic plasticity in the nucleus accumbens through GSK3β-dependent modulation of Kv4.2 channels
复制标题
DOI:
10.1073/pnas.1917423117
复制
发表时间:
2020-04-07
影响因子:
11.1
通讯作者:
Grassi, Claudio
中科院分区:
文献类型:
--
作者:
Aceto, Giuseppe;Colussi, Claudia;Grassi, Claudio
Although major depressive disorder (MDD) is highly prevalent, its pathophysiology is poorly understood. Recent evidence suggests that glycogen-synthase kinase 3 beta (GSK3 beta) plays a key role in memory formation, yet its role in mood regulation remains controversial. Here, we investigated whether GSK3 beta activity in the nucleus accumbens (NAc) is associated with depression-like behaviors and synaptic plasticity. We performed whole-cell patch-clamp recordings of medium spiny neurons (MSNs) in the NAc and determined the role of GSK3 beta in spike timing-dependent long-term potentiation (tLTP) in the chronic unpredictable mild stress (CUMS) mouse model of depression. To assess the specific role of GSK3 beta in tLTP, we used in vivo genetic silencing by an adeno-associated viral vector (AAV2) short hairpin RNA against GSK3 beta. In addition, we examined the role of the voltage-gated potassium Kv4.2 subunit, a molecular determinant of A-type K+ currents, as a potential downstream target of GSK3 beta. We found increased levels of active GSK3 beta and augmented tLTP in CUMS mice, a phenotype that was prevented by selective GSK3 beta knockdown. Furthermore, knockdown of GSK3 beta in the NAc ameliorated depressive-like behavior in CUMS mice. Electrophysiological, immunohistochemical, biochemical, and pharmacological experiments revealed that inhibition of the Kv4.2 channel through direct phosphorylation at Ser-616 mediated the GSK3 beta-dependent tLTP changes in CUMS mice. Our results identify GSK3 beta regulation of Kv4.2 channels as a molecular mechanism of MSN maladaptive plasticity underlying depression-like behaviors and suggest that the GSK3 beta-Kv4.2 axis may be an attractive therapeutic target for MDD.